0000000000496865

AUTHOR

Lara Valeska Maul

showing 1 related works from this author

The GERMELATOX DeCOG-trial: Attitude of German melanoma patients towards toxicity during adjuvant interferon treatment-Differences between the patien…

2015

e20099 Background: Although trials of adjuvant interferon alfa-2b (IFNa-2b) in high-risk melanoma patients suggest improvement in disease-free survival (DFS), metaanalyses showed only a marginal ov...

OncologyCancer Researchmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentMelanomaPerspective (graphical)medicine.diseaselanguage.human_languageGermanOncologyInterferonInternal medicineToxicityImmunologymedicinelanguagebusinessneoplasmsAdjuvantmedicine.drug
researchProduct